Cyklokapron T 500 FC Tablets And Cyklokapron Iv 500 Injection 500mg, 500mg / 5ml FC tablets, Injection
PDF Leaflet Revision Date: 10 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term use for haemorrhage or risk of haemorrhage.
Dosage (summary)
0.5-1 g IV or 1-2 tablets 2-3 times daily; adjust for renal impairment.
Special Populations
- Renal impairment
Pregnancy & Breastfeeding
Safety not established; avoid breastfeeding.
Contraindications
- Hypersensitivity to tranexamic acid
- Massive upper urinary tract haemorrhage
- Thrombotic tendency
- Impaired liver function
- Subarachnoid bleeding
- History of thromboembolism
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Allergic skin reactions
- Thromboembolic events
Counselling Points
- Do not breastfeed while using CYKLOKAPRON.
- Report any visual disturbances.
- Ensure correct administration route.
Serious warnings
- Risk of severe adverse reactions with incorrect administration route
- Convulsions reported with high doses
Important Disclaimer
The Cyklokapron T 500 FC Tablets And Cyklokapron Iv 500 Injection 500mg, 500mg / 5ml FC tablets, Injection professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
